History

Company PharmaMedicalGroup ALC was founded. The main activity was determined - work with the global companies in the field of pharmaceutics.

contract with the international pharmaceutical company Abbott Logistics was concluded. Promotion on the market of the Republic of Belarus of the last generation anesthetics - Chirocaine, Sevorane.

company Abbott Logistics declared the start of the process of demerger in two independent companies. PharmaMedicalGroup ALC concludes a contract with the newly founded company AbbVie - biopharmaceutical company engaged in the development of innovative drugs. PharmaMedicalGroup ALC begins promotion and marketing of the leading drugs in immunology and virology.

participation in the tender trade, contract with the Russian pharmaceutical company Ecomir, the Ukrainian pharmaceutical company Erbis was concluded. Development of a new direction - promotion and marketing of biologically active additives, vitamins, immunomodulatory products.

contract with Berlin-Chemie/Menarini was concluded. Cibor, Infesol, Altiazem RR, Refortan appeared in the product portfolio.

contract with the international company Forest Labs, manufacturer of a last generation potent antibiotic - Colomycin. Contract with the world leader in the field of specialized nutrition - Nutricia, which is part of the company Danone. Promotion and marketing of food products and specialized nutrition mixtures for people with rare genetic diseases. The range of specialized enteral nutrition is expanded. Arrangement of retail trade - opening of the first online store of specialized nutrition for people with rare genetic diseases in the Republic of Belarus.

new contracts with the global leaders in the field of medical equipment Pulsion/Make and transplantology XVIVO AB. Development of new directions - transplantology, medical equipment.

contract with the world leader in the field of drug development for therapy of orphan diseases company Genzyme, a subsidiary company of Sanofi, was concluded. The company is also known for its experience in the field of therapy of oncology diseases and multiple sclerosis.

strong need for modern antimicrobial drugs for the pharmaceutical market of the Republic of Belarus allowed PharmaMedicalGroup ALC to conclude an agreement with the leading Indian manufacturer in this field Lupin ltd., as well as company Hetero, one of the leading global manufacturers of key active pharmaceutical ingredients (API) and generics.

high quality equipment of medical and preventive treatment facilities of the Republic of Belarus expands diagnostic capabilities in such fields as oncology, ophthalmology, surgery, which requires modern contrast agents. PharmaMedicalGroup ALC concludes a contract with the company Green Diagnostics, Germany for supply of cyanine dye - Indocyanine green.

vast experience of PharmaMedicalGroup ALC in supply of pharmaceutical drugs for therapy of orphan diseases allowed to conclude a contract with the Italian company Recordati Rare Diseases, which mainly focuses on helping patients with rare pathologies.

contract between PharmaMedicalGroup ALC and Pharmstandard JSC, Russian Federation, created new possibilities in the available therapy of ultra-rare pathology, tuberculosis, hereditary blood diseases for patients in the Republic of Belarus.

Republic of Belarus, as well as the whole global community, faced a threat - COVID-19 pandemic. In the difficult time for our medicine and the population of the Republic of Belarus, PharmaMedicalGroup ALC, as a supplier of pharmaceutical drugs and medical devices, found an opportunity to provide aid in the form of donation of the drug Aluvia, medical face masks, protection screens.

the pandemic brought many hardships for the pharmaceutical market, as well as to the distributor of strategic pharmaceutical drugs. PharmaMedicalGroup ALC promptly handles this by supplying the unapproved pharmaceutical drugs under urgent requests of the Ministry of Health of the Republic of Belarus. To fulfill this task, PharmaMedicalGroup ALC concludes a contract with one of the biggest Russian distributors LANCET JSC, Russian Federation, and the Indian supplier SADAR BIOTECH PVT LTD., as well as company Fisher & Paykel Healthcare (New Zealand), manufacturer of respiratory therapy systems for patients with acute and chronic diseases.

PharmaMedicalGroup ALC develops a new direction - supply of immunobiological medicinal products for preventive vaccination from the world's largest vaccine manufacturer Serum Institute of India Pvt. Ltd, India is getting arranged.

the company makes a decision to start registration of critical medicines for therapy of oncology diseases, multiple sclerosis, IVF. For the implementation of this project an agreement between PharmaMedicalGroup ALC and Thesay Pharma Drug Store LLC., United Arab Emirates, was signed.

contract with the Spanish manufacturer of small molecules and biological pharmaceutical drugs Rovi was concluded.